SEC Form 4 · accession 0001140361-26-029193
Roivant Sciences Ltd. · ROIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Momtazee
Director
Period of report
Jul 17, 2026
Accepted (ET)
Jul 21, 2026 · 9:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001635088
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jul 17, 2026 | A | 405 | $0.00 | A | 109,810 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
Remarks
Exhibit 24 - Power of Attorney